Hospital begins monoclonal antibody treatment
Updated:
Updated:
Drug is said to bring down hospitalisation by 70%
Share Article
Drug is said to bring down hospitalisation by 70%
Kauvery Hospital in Chennai has treated a mildly symptomatic but high-risk COVID-19 patient with the monoclonal antibody cocktail that has been approved for emergency use in India. A statement issued by the hospital claimed that this was the first time the treatment had been used by a hospital in Tamil Nadu.
The individual was a cancer patient, who was recently diagnosed with early onset of renal failure, and hence was at higher risk of developing severe complications due to COVID-19.
Mixed monoclonal antibody treatment (Casirivimab and Imdevimab) is now available in India. The treatment gained popularity after then-US President Donald Trump was.
Mehul Choksi flees to Cuba fearing extradition; Roche’s Antibody Cocktail to treat COVID now available in India; Biden Welcomes call for sanctions on Belarus.